Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Proteomics. Clinical applications

Showing results (1-10 of 1,565) with videos related to

Pageof 157
Sort By:
Proteomics. Clinical Applications|June 23, 2021
Biomarkers for the central nervous system complications of sickle cell disease: are we there yet?Raffaele Renella
Proteomics. Clinical Applications|December 19, 2022
Fast and straightforward simultaneous quantification of multiple apolipoproteins in human serum on a high-throughput LC-MS/MS platformHyojin Kim, Won Suk Yang, Dongheui An, et al.
Proteomics. Clinical Applications|November 29, 2022
Two effective models based on comprehensive lipidomics and metabolomics can distinguish BC versus HCs, and TNBC versus non-TNBCYu Jin, Shuoqing Fan, Wenna Jiang, et al.
Proteomics. Clinical Applications|December 24, 2010
Impact of the storage temperature on human plasma proteomic analysis: implications for the use of human plasma collections in researchMaría Insenser, M Ángeles Martínez-García, Rafael Montes Nieto, et al.
Proteomics. Clinical Applications|February 16, 2011
Urinary CD14 as a potential biomarker for benign prostatic hyperplasia - discovery by combining MALDI-TOF-based biostatistics and ESI-MS/MS-based stable-isotope labelingHong-Lin Cheng, Hung-Jen Huang, Bing-Yuan Ou, et al.
Proteomics. Clinical Applications|February 1, 2011
Quantitative proteomics for investigating psychiatric disordersMichaela D Filiou, Christoph W Turck, Daniel Martins-de-Souza
Proteomics. Clinical Applications|January 20, 2011
Proteome analysis of biological fluids from autoimmune-rheumatological disordersLucia De Franceschi, Silvia Bosello, Cinzia Scambi, et al.
Proteomics. Clinical Applications|August 27, 2010
Systematic investigation of lycopene effects in LNCaP cells by use of novel large-scale proteomic analysis softwareYoung Ah Goo, Zheng Li, Natasa Pajkovic, et al.
Proteomics. Clinical Applications|December 25, 2010
A non-invasive method based on saliva to characterize transthyretin in familial amyloidotic polyneuropathy patients using FT-ICR high-resolution MSGonçalo da Costa, Ana Guerreiro, Catarina F Correia, et al.
Proteomics. Clinical Applications|April 15, 2011
Mapping of molecular pathways, biomarkers and drug targets for diabetic nephropathyRaul Fechete, Andreas Heinzel, Paul Perco, et al.
Pageof 157

Showing results (1-10 of 1,565) with videos related to

Sort By:
Pageof 157
Proteomics. Clinical Applications|June 23, 2021
Biomarkers for the central nervous system complications of sickle cell disease: are we there yet?Raffaele Renella
Proteomics. Clinical Applications|December 19, 2022
Fast and straightforward simultaneous quantification of multiple apolipoproteins in human serum on a high-throughput LC-MS/MS platformHyojin Kim, Won Suk Yang, Dongheui An, et al.
Proteomics. Clinical Applications|November 29, 2022
Two effective models based on comprehensive lipidomics and metabolomics can distinguish BC versus HCs, and TNBC versus non-TNBCYu Jin, Shuoqing Fan, Wenna Jiang, et al.
Proteomics. Clinical Applications|December 24, 2010
Impact of the storage temperature on human plasma proteomic analysis: implications for the use of human plasma collections in researchMaría Insenser, M Ángeles Martínez-García, Rafael Montes Nieto, et al.
Proteomics. Clinical Applications|February 16, 2011
Urinary CD14 as a potential biomarker for benign prostatic hyperplasia - discovery by combining MALDI-TOF-based biostatistics and ESI-MS/MS-based stable-isotope labelingHong-Lin Cheng, Hung-Jen Huang, Bing-Yuan Ou, et al.
Proteomics. Clinical Applications|February 1, 2011
Quantitative proteomics for investigating psychiatric disordersMichaela D Filiou, Christoph W Turck, Daniel Martins-de-Souza
Proteomics. Clinical Applications|January 20, 2011
Proteome analysis of biological fluids from autoimmune-rheumatological disordersLucia De Franceschi, Silvia Bosello, Cinzia Scambi, et al.
Proteomics. Clinical Applications|August 27, 2010
Systematic investigation of lycopene effects in LNCaP cells by use of novel large-scale proteomic analysis softwareYoung Ah Goo, Zheng Li, Natasa Pajkovic, et al.
Proteomics. Clinical Applications|December 25, 2010
A non-invasive method based on saliva to characterize transthyretin in familial amyloidotic polyneuropathy patients using FT-ICR high-resolution MSGonçalo da Costa, Ana Guerreiro, Catarina F Correia, et al.
Proteomics. Clinical Applications|April 15, 2011
Mapping of molecular pathways, biomarkers and drug targets for diabetic nephropathyRaul Fechete, Andreas Heinzel, Paul Perco, et al.
Pageof 157